Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches

Area of Science:

• Gynecologic Oncology
• Cancer Molecular Biology
• Surgical Pathology

Background:

• Uterine mesenchymal tumors (UMTs) are common, with smooth muscle neoplasms and endometrial stromal sarcomas (ESSs) being key subtypes.
• Endometrial stromal sarcomas (ESSs) are rare, aggressive malignancies known for molecular heterogeneity and challenging management, especially high-grade variants.

Purpose of the Study:

• To review current management strategies for endometrial stromal sarcomas (ESSs).
• To explore novel therapeutic approaches for ESSs based on recent molecular analyses.
• To highlight the need for improved treatments for advanced and recurrent ESS.

Main Methods:

• Literature review of recent advancements in molecular profiling of ESSs.
• Analysis of current therapeutic interventions, including surgery, radiation, chemotherapy, and hormonal therapy.
• Perspective on emerging targeted therapies for ESS.

Main Results:

• Surgery is the primary treatment for localized ESS, but adjuvant therapies require further investigation.
• Hormonal therapy shows efficacy in low-grade ESS but limited benefit in high-grade tumors.
• Molecular profiling reveals potential therapeutic targets for personalized ESS treatment.

Conclusions:

• Novel therapeutic strategies are crucial for improving outcomes in advanced and recurrent endometrial stromal sarcomas (ESSs).
• Personalized treatment approaches based on molecular insights hold promise for ESS management.
• Further research into adjuvant therapies and targeted treatments is essential for high-grade ESS.